Avoid alendronate if you have esophageal abnormalities, such as strictures or achalasia, as it can worsen these conditions. Proper posture and sufficient fluid intake are crucial when taking this medication to prevent esophageal irritation.
Patients with hypocalcemia should address this underlying condition before starting alendronate therapy. Calcium and vitamin D supplementation may be necessary to ensure adequate bone mineral density.
Renal impairment significantly affects alendronate elimination; dose adjustment or alternative treatments should be considered based on creatinine clearance. Regular monitoring of kidney function is recommended.
Alendronate may cause jaw osteonecrosis, particularly in patients with dental problems or those undergoing dental procedures. Consult your dentist before beginning alendronate treatment. Maintain excellent oral hygiene during therapy.
Atypical femoral fractures are a potential risk, especially with prolonged alendronate use. Regular bone density monitoring can help assess this risk.
Rarely, alendronate may cause severe muscle, joint, or bone pain. Report any significant pain to your physician immediately.
Pregnancy and breastfeeding are contraindications for alendronate use due to potential fetal harm. Reliable contraception should be used.
Always inform your doctor about all medications you are taking, including over-the-counter drugs and supplements, as interactions are possible.
